EN DE
Watch MetLife Inc for free: we tell you when fair value or trend changes.
Data-driven stock valuation

MetLife Inc (MET) fair value: what the stock is really worth

As of Nov 5, 2026: fair value (intrinsic value) of MetLife Inc stock $48.73, price $99.75, that is 51.1% below the price, quality 60 out of 100. Rating: strongly overvalued. Calculated from audited financials with 4 of our 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Financial Services US

MI MetLife Inc logo Broad data Nov 5, 2026

MetLife Inc

MET · US
Solid, but very expensive

Our calculation puts a fair price 51% below what the stock costs today.

Quality 60/100
2.3% dividend yield · Low payout
Positive coverage
Broad data
Mixed Growth (revenue 5y +2.6 %/yr in USD)
Thin margins · 4.6% net margin (TTM)
Mixed vs. peers (6/14)
Insiders sold $1.7M (6M)
Fair value $48.73 · Strongly overvalued (−51.1%)
Narrow moat 42/100 · thin data

Risks from the AI analysis

🚩PRT litigation challenges insurer selections🚩AI HR platforms commoditize group benefits admin
Watch MetLife Inc for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

$103.57 $44.57 Fair Value $48.73 Aug 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 5, 2026.

How to read this chart

60‑month range $44.57 – $103.57 · fair‑value band $41.89 – $63.63 · the $99.75 price screens above the $48.73 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 5, 2026.

Follow MetLife in your weekly email

Every Wednesday you see whether MetLife is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates in six segments: Group Benefits; Retirement and Income Solutions; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings.

Show moreShow less

The company offers life, dental, group short-and long-term disability, paid family and medical leave, individual disability, accidental death and dismemberment, accident and health, vision, and pet insurance, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

It also provides pension risk transfers, institutional income annuities, structured settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives.

In addition, it offers fixed, indexed-linked, and variable annuities; pension products; regular savings products; whole and term life, endowments, universal and variable life, and group life products; longevity and funded reinsurance solutions; credit insurance products; accident & health products covering hospitalization, cancer, critical illness, income protection, and scheduled medical reimbursement plans; and protection against long-term health care services.

The company was incorporated in 1999 and is based in New York, New York.

Stock analysis

MetLife Inc (MET) currently trades at $99.75, while our model-based Fair Value estimate is $48.73, 51% below the price, so the stock looks overvalued today.

Show more

Valuation

Bull case: the Multiples group reads highest at a median of $69.12 per share, and 0 of the 4 models we run sit above the $99.75 price.

Bear case: the Dividend Discount group reads lowest at $36.86, and 4 of the 4 models stay below the price. Data coverage for this calculation is high.

Scenario range: $41.89 (bear) to $63.63 (bull), the price of $99.75 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 60/100 (solid quality), in the Financial Services sector.

Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.

MetLife Inc reported revenue of $77.1B in FY2025 versus $63.4B in FY2021, a compound +5.0%/yr. Reported net income was $3.4B in FY2025, compounding −16.2%/yr from FY2021.

Key figures

Market cap $65.4B Large · P/E ratio 19.1 · P/S ratio 0.82 · EPS (TTM) $5.22 · Dividend yield 2.3% · Net margin 4.6% · Return on equity 13.1% · Return on assets (EBIT) 0.8%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 42 out of 100 (low confidence).

What moves the price

The share trades about 4% below its 52-week high and 49% above its 52-week low, currently above its 200-day average.

For context, the median of 10 Financial Services peers we cover trades at −36% fair-value upside, at −51%, MET screens richer than that median.

Fair Value models

Bear $41.89 Fair Value $48.73 Bull $63.63
Price $99.75 · Downside -51.1%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then ($2.48 per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
Residual Income $41.89 $48.73 $63.63 76
Gordon GGM $25.28 $40.02 $56.69 68
DDM Multi-Stage $25.28 $36.86 $50.28 66
All 4 models by family
Dividend Discount
Gordon GGM $25.28 $40.02 $56.69 68
DDM Multi-Stage $25.28 $36.86 $50.28 66
Multiples
P/E Multiple $51.84 $69.12 $86.41 63
Economic Profit
Residual Income $41.89 $48.73 $63.63 76

Open the full fair value analysis →

Quality Score breakdown

Overall quality 60/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 21
How much profit the company makes from its sales and capital
Quality Growth 53
Are margins and returns getting better?
Cashflow 94
Do the profits arrive as real cash?
Financial strength 10
Debt, balance sheet and risk of trouble
Investment 93
Does it invest with discipline instead of growing at any price?
Low Volatility 80
How calm the share price moves, does not count
Price momentum 62
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 77
Distance to the 52-week high, does not count
New shares 97
Buys back shares or issues new ones?

Open the full quality analysis →

Insider trades

In the last 6 months, one officer or director sold shares worth $1.7M and none bought.

  • SaleMarlene DebelEVP & Chief Risk Officer21,312 shares at $81.59$1.7MJun 1, 2026

Plus 43 other filings such as grants, option exercises or tax withholding. They are not market purchases or sales.

Sales are often planned (taxes, diversification, 10b5-1 plans). Purchases with their own money are seen as the stronger sign. For information only: not part of the quality score or Fair Value.

Source: SEC Form 4, as of Nov 5, 2026. All filings at the SEC ↗

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 68/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+8.6%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+4.3%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+2.6%
Start year 2020 (pandemic)
Revenue growth 8 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+2.7%
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Basis: adjusted.
−2.9%
Earnings growth per share plus dividend.
Earnings per share, growth per year−5.2%
Dividend (yield on the price)2.3%
Per share before 2017divided by the spin-off factor 1.122
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.−4.0% vs 1.8%, slowing
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.10% → 6%
Pace: the 5-year rate starts in 2020 (pandemic)

MET screens overvalued: fair value 51% below the price. Compare with Ping An Insurance (Group) Company →

Recent news

News mood ⓘNews mood, the average tone of recent news (100 articles), rated against how stocks are usually covered. 🚀 Hype = unusually upbeat · 🙂 Positive = above average · 😐 Neutral = typical · 🙁 Negative = below average · 😨 Very negative = unusually downbeat. It reflects the tone of coverage, not our valuation. Positive
Recent news coverage is more positive than average.
Note from the team Oct 11, 2026
AI conclusion: Moderate moat potential from scale in pension risk transfers stands against thin evidence on retention, efficiency and unique processes.
Main risk: Lawsuits alleging fiduciary breaches in selecting annuity providers for pension risk transfers could deter plan sponsors from using MetLife's solutions or force changes in deal structures and pricing.
Bull case: MetLife could deepen integrations with major HR platforms and leverage its data and scale to offer differentiated risk transfer and benefits solutions that sponsors continue to value despite litigation or automation trends.
Bear case: Sustained PRT lawsuits or successful commoditization by HR platforms might shrink MetLife's pension solutions pipeline and group benefits margins as sponsors shift to self-insured models or lower-cost alternatives.
Recent data shows record interest from pension sponsors in fully divesting liabilities through risk transfers. This points to steady demand for MetLife's pension solutions in a strong funding environment. Our models see the stock as overvalued. Will this growth engine offset other headwinds or fall short?
Join the discussion →

Compare MetLife Inc with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Insurance - Life · 77 stocks

Beats the industry median on 6/14 measures
A mixed picture versus its industry peers.
Valuation
Quality Score 60 · Top 25%
Fair Value upside −51.1% · Bottom 25%
Profitability
Return on equity (12 months) 13.1% · Above median
Return on assets 0.5% · Bottom 25%
Net margin (12 months) 4.6% · Bottom 25%
Operating margin (12 months) 5.5% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY) 10.5% · Above median
Dividend yield (12 months) 2.3% · Below median
Balance sheet
Debt / equity 0.66× · Highest 25%

Valuation Multiplesvs Insurance - Life median · lower = cheaper

P/E (12 months) 19.1× · Pricier than median
P/B 2.30× · book value is mostly goodwill ⓘGoodwill and other intangible assets are larger than the equity. The book value mainly reflects prices paid for past acquisitions, so we do not rank this P/B against the peer group.
P/S (12 months) 0.82× · Cheaper than median
Price / free cash flow (fiscal year) 3.6× · Cheaper than median
EV/EBITDA 10.3× · Pricier than median
PEG 0.53× · Cheapest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)0 · sector 6
FUTURE (revenue growth)53 · sector 38
PAST (return on equity)52 · sector 52
HEALTH (low debt)67 · sector 87
DIVIDEND (yield)46 · sector 55

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Insurance - Life stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
China Pacific Insurance (Group) Co 601601 ¥31.90 ¥48.28 +51% vs MET
Ping An Insurance (Group) Company 601318 ¥54.35 ¥66.91 +23% vs MET
China Life Insurance Company 601628 ¥35.85 ¥40.47 +13% vs MET
Life Insurance Corporation LICI ₹408.00 ₹299.42 −27% vs MET
Cathay Financial Holding 2882 112.00 TWD 71.53 TWD −36% vs MET
Manulife Financial Corporation MFC $43.99 $27.02 −39% vs MET
Aflac Incorporated AFL $126.24 $67.30 −47% vs MET
AIA Group 1299 HK$78.85 HK$41.63 −47% vs MET
Great-West Lifeco Inc GWO C$90.09 C$41.76 −54% vs MET
Power Corporation POW C$91.75 C$33.01 −64% vs MET

Explore undervalued stocks

More undervalued Financial Services stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Evidence & backtest34 years, failed companies included Financial calculatorsDCF, Graham, PEG and more
Run the numbers yourself: free valuation calculators
DCF CalculatorP/E Ratio CalculatorPEG Ratio CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorIntrinsic ValueIntrinsic vs Extrinsic ValueP/E Ratio by Sector
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

MetLife Inc: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "MetLife Inc Fair Value". https://www.fairvalue-calculator.com/stock/MET

Frequently asked questions

Is MetLife Inc (MET) overvalued or undervalued?
As of Nov 5, 2026, our model estimates a fair value of $48.73 versus a price of $99.75, about 51% lower (overvalued).
What is the fair value of MET?
Our model-based fair value for MetLife Inc is $48.73 (as of Nov 5, 2026), built from audited fundamentals. The current price: $99.75.
What is the quality score of MET?
MetLife Inc has a Quality Score of 60/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for MetLife Inc (MET)?
Our model-based price target is the fair value of $48.73 (as of Nov 5, 2026) from 4 valuation models. Cautious scenario $41.89, optimistic scenario $63.63. It is a calculation from audited fundamentals, not an analyst target.
What is the MetLife Inc stock forecast for 2026?
Our models put fair value at $48.73, about 51% lower versus a price of $99.75 (overvalued). Cautious scenario $41.89, optimistic scenario $63.63. The calculation is refreshed regularly with new filings.
What is the revenue of MetLife Inc (MET)?
MetLife Inc reported trailing-twelve-month revenue of about $79.4B (latest available figure, as of Nov 5, 2026).
Does MetLife Inc pay a dividend?
MetLife Inc currently shows a dividend yield of 2.30% relative to its recent price (as of Nov 5, 2026).
What is the intrinsic value of MetLife Inc (MET)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For MetLife Inc it is $48.73 per share (as of Nov 5, 2026), against a price of $99.75. It is the blended result of 4 valuation models (cash flow, earnings, asset, dividend).
Is MetLife Inc stock overvalued or undervalued in 2026?
As of Nov 5, 2026, MET trades above its calculated fair value: price $99.75, fair value $48.73, a gap of about −51% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of MET?
No. The price is what the market pays today ($99.75); the fair value is what the company's own numbers justify ($48.73). For MetLife Inc the two are $51.02 per share apart. That gap is exactly why we show both numbers side by side.
How much is MetLife Inc worth?
The market values MetLife Inc at about $65.4B (market capitalisation, as of Nov 5, 2026). Per share that is $99.75; our models calculate a fair value of $48.73 per share.
What do the bullish and bearish scenarios say about MET?
Our models span a range for MetLife Inc: cautious scenario $41.89, base $48.73, optimistic $63.63 per share (as of Nov 5, 2026, price $99.75). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of MET?
MetLife Inc trades at a price-to-earnings ratio of 19.1 (as of Nov 5, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of $48.73 is built from several models across several years. Median P/E at fiscal year-end, 9 fiscal years (2017 to 2025), reported earnings, 7 of the years ex one-offs: 10.5. Other multiples: PEG 0.5, P/B 2.3, P/S 0.8, EV/EBITDA 10.3.
What is the PEG ratio of MET?
The PEG ratio of MetLife Inc is 0.53 (P/E divided by earnings growth, as of Nov 5, 2026). That is below 1, so growth is priced more cheaply than the earnings multiple alone suggests.
How solid is the balance sheet of MetLife Inc (MET)?
Balance-sheet figures for MetLife Inc (as of Nov 5, 2026): return on equity 13.1%, debt of 0.66 per unit of equity. They feed the Quality Score of 60/100, which measures business quality independently of the share price.
How far is MET from its 52-week high?
MetLife Inc trades at $99.75, about 4% below its 52-week high of $103.57 and 49% above the low of $66.77 (as of Nov 5, 2026). Distance from the high says nothing about value: that is what the fair value of $48.73 is for.
Which stocks are comparable to MetLife Inc?
From the same area (Financial Services) we also value Ping An Insurance (Group) Company, China Life Insurance Company, AIA Group, Manulife Financial Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is MetLife Inc stock attractive at the current price?
The data as of Nov 5, 2026: price $99.75, calculated fair value $48.73 (−51%), Quality Score 60/100, from 4 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of MET calculated?
We run MetLife Inc through 4 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $48.73, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 15.5% above its aggregate fair value. MetLife Inc itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of MetLife Inc (MET)?
The closing price on Nov 5, 2026 was $99.75. Our model-based fair value is $48.73, about 51% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with MetLife Inc right now?
The price sits above even our optimistic bull case ($63.63). The favourable scenario is already priced in. Solid but not exceptional quality (60/100) and above fair value, neither a clear bargain nor a standout compounder. For a financial, book-value and earnings-based methods matter more than a cash-flow DCF, which fits banks and insurers poorly.
Where does the earnings growth of MetLife Inc (MET) come from?
Earnings per share at MetLife Inc grew +1.8 % a year from 2014 to 2025. Broken into its drivers: revenue per share +6.3 %, EBIT margin −4.7 %, tax rate +0.5 %, residual (interest, one-offs) +0.0 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.

Key figures of MetLife Inc

How large is the market capitalisation of MetLife Inc (MET)?
The market capitalisation of MetLife Inc is $65.4B. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of MetLife Inc (MET)?
The price-to-sales ratio of MetLife Inc is 0.82 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of MetLife Inc (MET)?
Earnings per share at MetLife Inc are $5.22 (price ÷ EPS = P/E 19.1). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of MetLife Inc (MET)?
The dividend yield of MetLife Inc is 2.3% (payout 44.0%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of MetLife Inc (MET)?
The net margin of MetLife Inc is 4.6% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of MetLife Inc (MET)?
The return on equity (ROE) of MetLife Inc is 13.1% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of MetLife Inc (MET)?
On an EBIT basis the return on assets of MetLife Inc is 0.8% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of MetLife Inc (MET)?
The operating margin of MetLife Inc is 5.5% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at MetLife Inc (MET)?
Revenue at MetLife Inc is growing +10.5% versus a year earlier (3y avg +4.3%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at MetLife Inc (MET)?
Earnings per share at MetLife Inc are growing +5.8% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does MetLife Inc (MET) generate?
The free cash flow of MetLife Inc is $18.1B (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net cash does MetLife Inc (MET) hold?
MetLife Inc holds more cash than debt, $1.8B net (fiscal year 2025). The company holds more cash than debt, a safety cushion.
Free · no account needed

Watch MetLife Inc in the live analysis

One click puts MetLife Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.